AFP - US drug watchdog wants tendinitis warning on common antibiotic
WASHINGTON (AFP) — The US Food and Drug Administration has asked manufacturers of antibiotics in the fluoroquinolone family to beef up warnings that taking the anti-microbial medication increases the risk of tendinitis or tendon rupture.
“Fluoroquinolones are effective in treating certain bacterial infections, but health care professionals and patients need to be aware of the increased risk associated with the use of these drugs of developing tendinitis and tendon rupture,” Edward Cox, director of the FDA’s Office of Antimicrobial Products, said in a statement issued Monday.
Related Results
WASHINGTON INSIDER: Update
Levaquin[R] receives FDA approval for treatment of chronic bacterial prostati…
Short-course Levaquin approved.(PRODUCTS)(Brief Article)
FDA grants approval for new oral solution of Levaquin
Pipeline
“The FDA believes it is important to highlight and strengthen information regarding possible side effects of fluoroquinolones because it may affect decisions about the relative risks and benefits associated with these products,” he said.
Fluoroquinolones, such …
Read the full article with a Free Trial at MyWire.
